Daniel Brooks
Editor & publisher, Sermorelin Hub
I bring more than 15 years of pharmaceutical R&D experience to the questions covered here. My background includes being a named inventor on multiple therapeutic patents, serving as program lead on programs that achieved FDA approvals, and building consumer and biotech businesses through multiple exits.
That experience shapes the way I read a provider’s page. I want to know what the evidence actually supports, which details are specific to the formulation, and where an appealing claim leaves important questions unanswered.
As an entrepreneur and a family man, I also care about the practical side: the total cost, the time commitment, and whether the next step is clear. Sermorelin Hub is where those perspectives meet.
What I bring to the reviews
A pharmaceutical development perspective and a consumer’s attention to the details. I review published offerings and explain the trade-offs in plain language. These articles do not represent individualized medical advice or a claim of clinical practice.
How to read my recommendations
Recommendations concern the information a provider publishes and the fit of its advertised offering for a stated preference. They do not guarantee safety, approval for treatment, or a health outcome. Research-based reviews are identified as such and do not imply personal use.
Read the editorial standards or contact the editor.
Profile revised October 2026.